ADIONA COVID-19 Antibody Test Platform Becomes First U.S. Solution to Marry Antibody Testing and Blockchain Technology

The following article was originally published by Business Wire:

IRVINE, Calif.–(BUSINESS WIRE)–Kahala Biosciences LLC, an Irvine-based COVID-19 testing and tracking company, and technology partner Rymedi, Inc., a Greenville, South Carolina-based developer of blockchain-based protocols and solutions for complex life sciences and pharmaceuticals, today announced the ADIONA™ COVID-19 antibody testing platform, the first system available in the U.S. that integrates antibody testing with a blockchain-based smartphone software application to bring predictability and traceability to COVID-19 antibody testing. Antibody testing is used to determine if someone has been previously infected with the COVID-19 virus and may have developed immunity.

Read Full Article >

Categories
Archives
READY TO LEARN MORE?

Connected Health Starts Here